Orders from 465 AED Free delivery from 965 AED Ready for pickup dead drop: collect in 5 min

Substances · Phenethylamine derivatives

3-FA

C9H12FN CAS 1626-71-7 Analytical reference material — not for human consumption
Preferred name
3-FA
IUPAC name
1-(3-fluorophenyl)propan-2-amine
Parent CAS number (reference)
1626-71-7
Molecular formula
C9H12FN
Molecular weight
153.2 g/mol
InChIKey
PIOCLGPCMNPZFT-UHFFFAOYSA-N
PubChem
CID 121501
Source
PubChem
Verified synonyms & catalog abbreviations
3-Fluoroamphetamine PAL-353 3FA 3 FA

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

3-FA

Stimulant (dopamine/norepinephrine releaser) Ring-fluorinated amphetamine (meta-fluoro)
Verified PubChem & CAS Identity C9H12FN · CAS 1626-71-7 · CID 121501
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 153.20 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

3-FA (PAL-353) is the meta-fluoro primary amine. In the fluorinated amphetamine set it is the dopaminergic, mood-elevating stimulant: more recreational than 2-FMA, less serotonergic than 4-FA, and shorter than 2-FMA. PsychonautWiki describes it as producing classical stimulant effects with a claimed potency in the neighborhood of methamphetamine. That comparison is a risk statement, not a quantitative brackets equivalence.

Biotransformation & Active Metabolites

The parent amine is active. It is not N-methylated 2-FMA and it is not para-fluoro 4-FA (CAS 459-02-9), even though the formula C9H12FN and the mass 153.20 g/mol match 4-FA exactly.

Temporal Pharmacokinetics

Classic dopaminergic stimulant: mood elevation, drive, and talkativeness with a moderate duration and a noticeable comedown.

  1. Onset 20–60 minutes
  2. Peak Window 2–3 hours
  3. Total Window 4–6 hours
  4. Residual / Half-Life After-effects 2–6 hours of fatigue, low mood, and insomnia. Human half-life is not established.

Threshold 10 mg, light 20–30 mg, common 30–50 mg, strong 50–70 mg, heavy above 70 mg. Duration 4–6 hours is shorter than 2-FMA, which encourages a second dose. The second dose mostly adds vasoconstriction and a worse crash.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
10 mg
Cognitive & Sensory

A mild lift in energy and mood.

Somatic & Autonomic

Slight dry mouth and pulse increase.

Light
20–30 mg
Cognitive & Sensory

Clean stimulation, increased confidence, and light mood elevation.

Somatic & Autonomic

Appetite suppression and mild bruxism.

Common Reference
30–50 mg
Cognitive & Sensory

Obvious mood elevation, talkativeness, and driven focus that easily becomes scattered.

Somatic & Autonomic

Tachycardia, sweating, jaw tension, and vasoconstriction.

Strong
50–70 mg
Cognitive & Sensory

Intense stimulation, irritability, and compulsive repeated exposure thoughts as the peak fades.

Somatic & Autonomic

Tremor, cold extremities, urinary difficulty, and a hard crash later.

Heavy / Toxic Zone
70 mg+
Cognitive & Sensory

Agitation, paranoia, and stimulant confusion.

Somatic & Autonomic

Hypertensive strain, chest pain, severe insomnia, and seizures with tramadol or an MAOI.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

25x-NBOMe and 25x-NBOH

Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Elevated Hazard — Avoid

Other stimulants, cocaine, and high-dose caffeine

Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.

Alcohol, opioids, and benzodiazepines

The stimulant hides sedation. When it drops, the depressant remains.

Caution / Receptor Attenuation

Cannabis

Often increases heart rate and paranoid thought on the offset.

SSRIs and SNRIs

Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.

Structural Isomer & Sibling Comparison

3-FA and 4-FA are formula isomers (C9H12FN, 153.20 g/mol) with different CAS numbers and different oral bands. 3-FA common is 30–50 mg of a dopaminergic stimulant lasting 4–6 hours. 4-FA common is 100–130 mg and only becomes entactogenic in that higher band, with a stroke warning above 150 mg. 2-FMA is longer and flatter (15–30 mg, 7–9 hours). Swapping 3-FA and 4-FA by the shared formula is a serious quantitative brackets error.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

Fast stimulant tolerance and a high compulsion to redose because the peak is only 2–3 hours. Cross-tolerance with amphetamines. Crash includes low mood and exhaustion. Spacing of several days reduces tolerance; it does not remove cardiovascular strain from a binge.

Comprehensive Analytical & Toxicological Monograph

3-FA (1-(3-fluorophenyl)propan-2-amine; PAL-353; CAS 1626-71-7, PubChem CID 121501) is the meta-fluorinated amphetamine supplied as pure powder or crystals (C9H12FN, 153.20 g/mol). It is a dopamine/norepinephrine stimulant, more mood-elevating than 2-FMA and less serotonergic than 4-FA. PsychonautWiki oral bands are threshold 10 mg, light 20–30 mg, common 30–50 mg, strong 50–70 mg, and heavy above 70 mg, over 4–6 hours. It shares the molecular formula with 4-FA (CAS 459-02-9) but not the dose: 4-FA's common band starts at 100 mg. Do not combine with MAOIs, tramadol, other stimulants, or 25x-NBOMe.

Chemical Architecture & Structural Profile

3-FA (1-(3-fluorophenyl)propan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C9H12FN and a molar mass of 153.2 g/mol. The parent molecule is indexed under CAS registry number 1626-71-7 and in the NCBI PubChem database as CID 121501 (Standard InChIKey: PIOCLGPCMNPZFT-UHFFFAOYSA-N). This molecule shares its empirical formula (C9H12FN) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1626-71-7), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 3-FA is indexed within the Amphetamine, Substituted amphetamines structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)